Cardiff Oncology: HC Wainwright Raises PT to $10, Maintains Buy Rating.

miércoles, 28 de enero de 2026, 12:31 pm ET1 min de lectura
CRDF--

Cardiff Oncology: HC Wainwright Raises PT to $10, Maintains Buy Rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios